Prospective Study for the Evaluation of the Cementless Anatomic Femoral Stem Minimax -Launay

Medacta

Status: Active, not recruiting

Conditions: Secondary Osteoarthritis; Fracture; Femur, Head; Traumatic Arthritis; Congenital Hip Dysplasia; Avascular Necrosis; Primary Osteoarthritis; Rheumatoid Arthritis

Treatments: Device: MiniMAX

Study type: Observational

Funder types: Industry

Identifiers

NCT06012656

P01.005.10

Details and patient eligibility

About

This is a post-marketing surveillance on MiniMAX Stem

Enrollment: 100 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patient with a clinical condition requiring THA
2. Patient receiving a MiniMAX® stem
3. Patient aged more than 18 years
4. Patient having a Social Insurance or a similar protection regime
5. Patient eligible for an AMIS procedure
6. Patient able to follow the study requirements
7. Patients who are willing to give informed written consent

Exclusion criteria

1. Patient with local or systemic infection
2. Participation to biomedical research
3. Patient whose BMI exceeds 40
4. Patient with less than 18 years
5. Protected adults
6. Vulnerable person according to article L1121-6 of the Code de la Santè Publique.
7. Pregnant or lactating woman
8. Patient unable to express his/ her opinion about the participation to the study